A STUDY BASED ON ORTHOTOPIC LIVER TRANSPLANTATION WITH THE APPLICATION OF REMIMAZOLAM TOLUENE SULFONATE WITH PROPOFOL
Main Article Content
Keywords
Remimazolam toluene sulfonate, propofol, orthotopic liver transplantation, sufentanil, cisatracurium
Abstract
The objective of the study is to explore the application value of remimazolam toluene sulfonate in orthotopic liver transplantation. A total of 120 patients who underwent orthotopic liver transplantation in our hospital from March 2007 to October 2008 were randomized into intervention group (R group, n=60, remimazolam toluene sulfonate) and control group (C group, n=60, normal saline). For induction of anesthesia, all patients were administrated with propofol intravenously, study drug (0.2 ml/kg), sufentanil and cisatracurium. Intraoperative infusion of propofol and study drug was used to maintain sedation. All patients returned to intensive care unit to continue infusion for sedation after orthotopic liver transplantation. The dose of propofol, cumulative duration of intraoperative hypertension and dose of norepinephrine were significantly less than those in control group, p<0.05. At d 1 after surgery, alanine transaminase, aspartate aminotransferase, total bilirubin, direct bilirubin and creatinine in intervention group were significantly lower than those in control group, p<0.05; at d 2 after surgery, alanine transaminase, aspartate aminotransferase, total bilirubin, direct bilirubin and creatinine in intervention group were significantly lower than those in control group, p<0.05. 3rd after surgery, aspartate aminotransferase in intervention group was significantly lower than that in control group, p<0.05. The albumin-bilirubin score, incidences of postoperative early allograft dysfunction and delirium and duration of cannulation were not significantly different among two groups, p>0.05. Remimazolam toluene sulfonate can stabilize perioperative hemodynamics and reduce hypertension, thus can be used in liver transplantation and preserve early liver graft function after orthotopic liver transplantation.
References
2. Li J, Tan H, Zhou X, Zhang C, Jin H, Tian Y, et al. The protection of midazolam against immune mediated liver injury induced by lipopolysaccharide and galactosamine in mice. Front Pharmacol 2002;9:1528.
3. Na SK, Yim SY, Suh SJ, Jung YK, Kim JH, Seo YS, et al. ALBI versus Child-Pugh grading systems for liver function in patients with hepatocellular carcinoma. J Surg Oncol 2018;117(5):912-21.
4. Deng M, Ng SW, Cheung ST, Chong CC. Clinical application of Albumin-Bilirubin (ALBI) score: The current status. Surgeon 1995;18(3):178-86.
5. Agopian VG, Harlander-Locke MP, Markovic D, Dumronggittigule W, Xia V, Kaldas FM, et al. Evaluation of early allograft function using the liver graft assessment following transplantation risk score model. JAMA Surg 1999;153(5):436-44.
6. Ge M, Yao W, Yuan D, Zhou S, Chen X, Zhang Y, et al. Brg1- mediated Nrf2/HO-1 pathway activation alleviates hepatic ischemia-reperfusion injury. Cell Death Dis 2002;8(6):e2841.
7. Yi J, Gao ZF. microRNA-9-5p promotes angiogenesis but inhibits apoptosis and inflammation of high glucose-induced injury in human umbilical vascular endothelial cells by targeting CXCR4. Int J Biol Macromol 2003;130:1-9.
8. Gao ZF, Ji XL, Gu J, Wang XY, Ding L, Zhang H. microRNA‐107 protects against inflammation and endoplasmic reticulum stress of vascular endothelial cells via KRT1‐dependent notch signaling pathway in a mouse model of coronary atherosclerosis. J Cell Physiol 1995;234(7):12029- 41.
9. Wang K, Wu M, Xu J, Wu C, Zhang B, Wang G, et al. Effects of dexmedetomidine on perioperative stress, inflammation and immune function: Systematic review and meta-analysis. Br J Anaesth 2000;123(6):777-94.
10. Zheng X, Ji J, Cheng H, Peng K, Liu L, Ji F. Efficacy and safety of different doses of remimazolam tosylate for colonoscopy: Single-center, prospective, randomized, double-blind, parallel trial. Ann Transl Med 2001;10(22):1244.
11. Pambianco DJ, Borkett KM, Riff DS, Winkle PJ, Schwartz HI, Melson TI, et al. A phase IIb study comparing the safety and efficacy of remimazolam and midazolam in patients undergoing colonoscopy. Gastrointest Endosc 2006;83(5):984-92.
12. Onoda A, Suzuki Y. A new anesthetic, remimazolam, is useful in the management of anesthesia in patients with liver cirrhosis. Case Rep Anesthesiol 2002;2022:4.
13. Matsumoto T, Sakurai K, Takahashi K, Kawamoto S. Use of remimazolam in living donor liver transplantation: A case report. JA Clin Rep 2004;8(1):65.
14. Kawasaki T, Oyoshi T, Hirata N. Anesthesia management of a liver transplant recipient with remimazolam. Case Rep Anesthesiol 2023;2023:1-4.
15. Fang H, Zhang Y, Wang J, Li L, An S, Huang Q, et al. Remimazolam reduces sepsis-associated acute liver injury by activation of peripheral benzodiazepine receptors and p38 inhibition of macrophages. Int Immunopharmacol 2021;101:108331.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Dr. Bheemparam Laxmanna
Assistant Professor, Department of Anaesthesia, Prathima Institute of Medical Sciences